Danielle De Merieux, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3541 Washington Blvd Ste 110, Arbutus, MD 21227 Phone: 443-543-9914 |
News Archive
A study published in the peer reviewed Journal of Translational Medicine demonstrated administration of Stem-Kine, a commercially available nutritional supplement, significantly elevated levels of two types of stem cells in circulation.
Schering-Plough Corporation today announced that the European Commission has approved the use of Remicade (infliximab) as monotherapy in the treatment of active and progressive psoriatic arthritis (PsA) in patients who show intolerance to methotrexate or for whom methotrexate is contraindicated.
A recent study has demonstrated that SARS-CoV-2 infection induces a significantly lower interferon response than rhinovirus infection.
The Radiation Oncology Department at Thomas Jefferson University Hospitals is now treating cancer patients using a state-of-the-art VMAT technology based on the most accurate dose calculation algorithm that dramatically shortens treatment delivery time.
The U.S. Food and Drug Administration recently approved the injectable drug degarelix, the first new drug in several years for prostate cancer.
› Verified 6 days ago